These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

594 related items for PubMed ID: 6611141

  • 21. [Molecular mechanisms of tumor and immune system interaction].
    Berezhnoĭ AE, Gnuchev NV, Georgiev GP, Kozlov AM, Larin SS.
    Vopr Onkol; 2008; 54(6):669-83. PubMed ID: 19241839
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Effect of immune processes on the growth and regression of malignant tumors].
    Russo V, Russo L.
    Vopr Onkol; 1974; 20(6):68-75. PubMed ID: 4603500
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Central issues in present-day tumor immunology: interpretation of lymphocytotoxicity assays and the demonstration of auto-tumor-reactive lymphocytes in patients.
    Klein E.
    Transplant Proc; 1981 Mar; 13(1 Pt 2):723-8. PubMed ID: 6168071
    [No Abstract] [Full Text] [Related]

  • 26. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
    Herskind C, Fleckenstein K, Lohr J, Li CY, Wenz F, Lohr F.
    Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Principles and use of anti-CTLA4 antibody in human cancer immunotherapy.
    Peggs KS, Quezada SA, Korman AJ, Allison JP.
    Curr Opin Immunol; 2006 Apr; 18(2):206-13. PubMed ID: 16464564
    [Abstract] [Full Text] [Related]

  • 32. Functions of natural killer cells.
    Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S.
    Nat Immunol; 2008 May; 9(5):503-10. PubMed ID: 18425107
    [Abstract] [Full Text] [Related]

  • 33. MHC class I-related chain A conjugated to antitumor antibodies can sensitize tumor cells to specific lysis by natural killer cells.
    Germain C, Larbouret C, Cesson V, Donda A, Held W, Mach JP, Pèlegrin A, Robert B.
    Clin Cancer Res; 2005 Oct 15; 11(20):7516-22. PubMed ID: 16243826
    [Abstract] [Full Text] [Related]

  • 34. Progress in human tumour immunology and immunotherapy.
    Rosenberg SA.
    Nature; 2001 May 17; 411(6835):380-4. PubMed ID: 11357146
    [Abstract] [Full Text] [Related]

  • 35. Human interleukin 2: molecular biology, physiology and clinical possibilities.
    Mertelsmann R, Welte K.
    Immunobiology; 1986 Sep 17; 172(3-5):400-19. PubMed ID: 3100434
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Bispecific antibodies and diabodies for cancer immunotherapy.
    Elsässer-Beile U, Bühler P.
    Immunotherapy; 2012 May 17; 4(5):459-60. PubMed ID: 22642325
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.